Pharma & Healthcare
Global PEGylated Proteins Market Research Report 2024
- Jan 26, 24
- ID: 39426
- Pages: 85
- Figures: 185
- Views: 21
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The global PEGylated Proteins market was valued at US$ 3769 million in 2023 and is anticipated to reach US$ 4908.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
This report aims to provide a comprehensive presentation of the global market for PEGylated Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylated Proteins.
Report Scope
The PEGylated Proteins market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PEGylated Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylated Proteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEGylated Proteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEGylated Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global PEGylated Proteins market was valued at US$ 3769 million in 2023 and is anticipated to reach US$ 4908.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
This report aims to provide a comprehensive presentation of the global market for PEGylated Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylated Proteins.
Report Scope
The PEGylated Proteins market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PEGylated Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylated Proteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEGylated Proteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEGylated Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 PEGylated Proteins Market Overview
1.1 Product Overview and Scope of PEGylated Proteins
1.2 PEGylated Proteins Segment by Type
1.2.1 Global PEGylated Proteins Market Value Comparison by Type (2024-2030)
1.2.2 Colony Stimulating Factors
1.2.3 Interferons
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor VIII
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 PEGylated Proteins Segment by Application
1.3.1 Global PEGylated Proteins Market Value by Application: (2024-2030)
1.3.2 Cancer Treatment
1.3.3 Hepatitis
1.3.4 Chronic Kidney Disease
1.3.5 Leukemia
1.3.6 SCID
1.3.7 Rheumatoid Arthritis & Crohn's Disease
1.3.8 Others
1.4 Global PEGylated Proteins Market Size Estimates and Forecasts
1.4.1 Global PEGylated Proteins Revenue 2019-2030
1.4.2 Global PEGylated Proteins Sales 2019-2030
1.4.3 Global PEGylated Proteins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PEGylated Proteins Market Competition by Manufacturers
2.1 Global PEGylated Proteins Sales Market Share by Manufacturers (2019-2024)
2.2 Global PEGylated Proteins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PEGylated Proteins Average Price by Manufacturers (2019-2024)
2.4 Global PEGylated Proteins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PEGylated Proteins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PEGylated Proteins, Product Type & Application
2.7 PEGylated Proteins Market Competitive Situation and Trends
2.7.1 PEGylated Proteins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PEGylated Proteins Players Market Share by Revenue
2.7.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PEGylated Proteins Retrospective Market Scenario by Region
3.1 Global PEGylated Proteins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PEGylated Proteins Global PEGylated Proteins Sales by Region: 2019-2030
3.2.1 Global PEGylated Proteins Sales by Region: 2019-2024
3.2.2 Global PEGylated Proteins Sales by Region: 2025-2030
3.3 Global PEGylated Proteins Global PEGylated Proteins Revenue by Region: 2019-2030
3.3.1 Global PEGylated Proteins Revenue by Region: 2019-2024
3.3.2 Global PEGylated Proteins Revenue by Region: 2025-2030
3.4 North America PEGylated Proteins Market Facts & Figures by Country
3.4.1 North America PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PEGylated Proteins Sales by Country (2019-2030)
3.4.3 North America PEGylated Proteins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PEGylated Proteins Market Facts & Figures by Country
3.5.1 Europe PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PEGylated Proteins Sales by Country (2019-2030)
3.5.3 Europe PEGylated Proteins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PEGylated Proteins Market Facts & Figures by Country
3.6.1 Asia Pacific PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PEGylated Proteins Sales by Country (2019-2030)
3.6.3 Asia Pacific PEGylated Proteins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PEGylated Proteins Market Facts & Figures by Country
3.7.1 Latin America PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PEGylated Proteins Sales by Country (2019-2030)
3.7.3 Latin America PEGylated Proteins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PEGylated Proteins Market Facts & Figures by Country
3.8.1 Middle East and Africa PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PEGylated Proteins Sales by Country (2019-2030)
3.8.3 Middle East and Africa PEGylated Proteins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PEGylated Proteins Sales by Type (2019-2030)
4.1.1 Global PEGylated Proteins Sales by Type (2019-2024)
4.1.2 Global PEGylated Proteins Sales by Type (2025-2030)
4.1.3 Global PEGylated Proteins Sales Market Share by Type (2019-2030)
4.2 Global PEGylated Proteins Revenue by Type (2019-2030)
4.2.1 Global PEGylated Proteins Revenue by Type (2019-2024)
4.2.2 Global PEGylated Proteins Revenue by Type (2025-2030)
4.2.3 Global PEGylated Proteins Revenue Market Share by Type (2019-2030)
4.3 Global PEGylated Proteins Price by Type (2019-2030)
5 Segment by Application
5.1 Global PEGylated Proteins Sales by Application (2019-2030)
5.1.1 Global PEGylated Proteins Sales by Application (2019-2024)
5.1.2 Global PEGylated Proteins Sales by Application (2025-2030)
5.1.3 Global PEGylated Proteins Sales Market Share by Application (2019-2030)
5.2 Global PEGylated Proteins Revenue by Application (2019-2030)
5.2.1 Global PEGylated Proteins Revenue by Application (2019-2024)
5.2.2 Global PEGylated Proteins Revenue by Application (2025-2030)
5.2.3 Global PEGylated Proteins Revenue Market Share by Application (2019-2030)
5.3 Global PEGylated Proteins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ENZON Pharmaceuticals
6.1.1 ENZON Pharmaceuticals Corporation Information
6.1.2 ENZON Pharmaceuticals Description and Business Overview
6.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ENZON Pharmaceuticals PEGylated Proteins Product Portfolio
6.1.5 ENZON Pharmaceuticals Recent Developments/Updates
6.2 Merck Sharp & Dohme
6.2.1 Merck Sharp & Dohme Corporation Information
6.2.2 Merck Sharp & Dohme Description and Business Overview
6.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Sharp & Dohme PEGylated Proteins Product Portfolio
6.2.5 Merck Sharp & Dohme Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche PEGylated Proteins Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer PEGylated Proteins Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen PEGylated Proteins Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 UCB
6.6.1 UCB Corporation Information
6.6.2 UCB Description and Business Overview
6.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 UCB PEGylated Proteins Product Portfolio
6.6.5 UCB Recent Developments/Updates
6.7 Crealta (Savient)
6.6.1 Crealta (Savient) Corporation Information
6.6.2 Crealta (Savient) Description and Business Overview
6.6.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Crealta (Savient) PEGylated Proteins Product Portfolio
6.7.5 Crealta (Savient) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PEGylated Proteins Industry Chain Analysis
7.2 PEGylated Proteins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PEGylated Proteins Production Mode & Process
7.4 PEGylated Proteins Sales and Marketing
7.4.1 PEGylated Proteins Sales Channels
7.4.2 PEGylated Proteins Distributors
7.5 PEGylated Proteins Customers
8 PEGylated Proteins Market Dynamics
8.1 PEGylated Proteins Industry Trends
8.2 PEGylated Proteins Market Drivers
8.3 PEGylated Proteins Market Challenges
8.4 PEGylated Proteins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of PEGylated Proteins
1.2 PEGylated Proteins Segment by Type
1.2.1 Global PEGylated Proteins Market Value Comparison by Type (2024-2030)
1.2.2 Colony Stimulating Factors
1.2.3 Interferons
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor VIII
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 PEGylated Proteins Segment by Application
1.3.1 Global PEGylated Proteins Market Value by Application: (2024-2030)
1.3.2 Cancer Treatment
1.3.3 Hepatitis
1.3.4 Chronic Kidney Disease
1.3.5 Leukemia
1.3.6 SCID
1.3.7 Rheumatoid Arthritis & Crohn's Disease
1.3.8 Others
1.4 Global PEGylated Proteins Market Size Estimates and Forecasts
1.4.1 Global PEGylated Proteins Revenue 2019-2030
1.4.2 Global PEGylated Proteins Sales 2019-2030
1.4.3 Global PEGylated Proteins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PEGylated Proteins Market Competition by Manufacturers
2.1 Global PEGylated Proteins Sales Market Share by Manufacturers (2019-2024)
2.2 Global PEGylated Proteins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PEGylated Proteins Average Price by Manufacturers (2019-2024)
2.4 Global PEGylated Proteins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PEGylated Proteins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PEGylated Proteins, Product Type & Application
2.7 PEGylated Proteins Market Competitive Situation and Trends
2.7.1 PEGylated Proteins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PEGylated Proteins Players Market Share by Revenue
2.7.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PEGylated Proteins Retrospective Market Scenario by Region
3.1 Global PEGylated Proteins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PEGylated Proteins Global PEGylated Proteins Sales by Region: 2019-2030
3.2.1 Global PEGylated Proteins Sales by Region: 2019-2024
3.2.2 Global PEGylated Proteins Sales by Region: 2025-2030
3.3 Global PEGylated Proteins Global PEGylated Proteins Revenue by Region: 2019-2030
3.3.1 Global PEGylated Proteins Revenue by Region: 2019-2024
3.3.2 Global PEGylated Proteins Revenue by Region: 2025-2030
3.4 North America PEGylated Proteins Market Facts & Figures by Country
3.4.1 North America PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PEGylated Proteins Sales by Country (2019-2030)
3.4.3 North America PEGylated Proteins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PEGylated Proteins Market Facts & Figures by Country
3.5.1 Europe PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PEGylated Proteins Sales by Country (2019-2030)
3.5.3 Europe PEGylated Proteins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PEGylated Proteins Market Facts & Figures by Country
3.6.1 Asia Pacific PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PEGylated Proteins Sales by Country (2019-2030)
3.6.3 Asia Pacific PEGylated Proteins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PEGylated Proteins Market Facts & Figures by Country
3.7.1 Latin America PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PEGylated Proteins Sales by Country (2019-2030)
3.7.3 Latin America PEGylated Proteins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PEGylated Proteins Market Facts & Figures by Country
3.8.1 Middle East and Africa PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PEGylated Proteins Sales by Country (2019-2030)
3.8.3 Middle East and Africa PEGylated Proteins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PEGylated Proteins Sales by Type (2019-2030)
4.1.1 Global PEGylated Proteins Sales by Type (2019-2024)
4.1.2 Global PEGylated Proteins Sales by Type (2025-2030)
4.1.3 Global PEGylated Proteins Sales Market Share by Type (2019-2030)
4.2 Global PEGylated Proteins Revenue by Type (2019-2030)
4.2.1 Global PEGylated Proteins Revenue by Type (2019-2024)
4.2.2 Global PEGylated Proteins Revenue by Type (2025-2030)
4.2.3 Global PEGylated Proteins Revenue Market Share by Type (2019-2030)
4.3 Global PEGylated Proteins Price by Type (2019-2030)
5 Segment by Application
5.1 Global PEGylated Proteins Sales by Application (2019-2030)
5.1.1 Global PEGylated Proteins Sales by Application (2019-2024)
5.1.2 Global PEGylated Proteins Sales by Application (2025-2030)
5.1.3 Global PEGylated Proteins Sales Market Share by Application (2019-2030)
5.2 Global PEGylated Proteins Revenue by Application (2019-2030)
5.2.1 Global PEGylated Proteins Revenue by Application (2019-2024)
5.2.2 Global PEGylated Proteins Revenue by Application (2025-2030)
5.2.3 Global PEGylated Proteins Revenue Market Share by Application (2019-2030)
5.3 Global PEGylated Proteins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ENZON Pharmaceuticals
6.1.1 ENZON Pharmaceuticals Corporation Information
6.1.2 ENZON Pharmaceuticals Description and Business Overview
6.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ENZON Pharmaceuticals PEGylated Proteins Product Portfolio
6.1.5 ENZON Pharmaceuticals Recent Developments/Updates
6.2 Merck Sharp & Dohme
6.2.1 Merck Sharp & Dohme Corporation Information
6.2.2 Merck Sharp & Dohme Description and Business Overview
6.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Sharp & Dohme PEGylated Proteins Product Portfolio
6.2.5 Merck Sharp & Dohme Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche PEGylated Proteins Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer PEGylated Proteins Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen PEGylated Proteins Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 UCB
6.6.1 UCB Corporation Information
6.6.2 UCB Description and Business Overview
6.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 UCB PEGylated Proteins Product Portfolio
6.6.5 UCB Recent Developments/Updates
6.7 Crealta (Savient)
6.6.1 Crealta (Savient) Corporation Information
6.6.2 Crealta (Savient) Description and Business Overview
6.6.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Crealta (Savient) PEGylated Proteins Product Portfolio
6.7.5 Crealta (Savient) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PEGylated Proteins Industry Chain Analysis
7.2 PEGylated Proteins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PEGylated Proteins Production Mode & Process
7.4 PEGylated Proteins Sales and Marketing
7.4.1 PEGylated Proteins Sales Channels
7.4.2 PEGylated Proteins Distributors
7.5 PEGylated Proteins Customers
8 PEGylated Proteins Market Dynamics
8.1 PEGylated Proteins Industry Trends
8.2 PEGylated Proteins Market Drivers
8.3 PEGylated Proteins Market Challenges
8.4 PEGylated Proteins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global PEGylated Proteins Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global PEGylated Proteins Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global PEGylated Proteins Market Competitive Situation by Manufacturers in 2023
Table 4. Global PEGylated Proteins Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global PEGylated Proteins Sales Market Share by Manufacturers (2019-2024)
Table 6. Global PEGylated Proteins Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global PEGylated Proteins Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market PEGylated Proteins Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of PEGylated Proteins, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PEGylated Proteins, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PEGylated Proteins, Product Type & Application
Table 12. Global Key Manufacturers of PEGylated Proteins, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PEGylated Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylated Proteins as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PEGylated Proteins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global PEGylated Proteins Sales by Region (2019-2024) & (K MT)
Table 18. Global PEGylated Proteins Sales Market Share by Region (2019-2024)
Table 19. Global PEGylated Proteins Sales by Region (2025-2030) & (K MT)
Table 20. Global PEGylated Proteins Sales Market Share by Region (2025-2030)
Table 21. Global PEGylated Proteins Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global PEGylated Proteins Revenue Market Share by Region (2019-2024)
Table 23. Global PEGylated Proteins Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global PEGylated Proteins Revenue Market Share by Region (2025-2030)
Table 25. North America PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 27. North America PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 28. North America PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 32. Europe PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 33. Europe PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific PEGylated Proteins Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific PEGylated Proteins Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific PEGylated Proteins Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific PEGylated Proteins Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific PEGylated Proteins Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 42. Latin America PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 43. Latin America PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global PEGylated Proteins Sales (K MT) by Type (2019-2024)
Table 51. Global PEGylated Proteins Sales (K MT) by Type (2025-2030)
Table 52. Global PEGylated Proteins Sales Market Share by Type (2019-2024)
Table 53. Global PEGylated Proteins Sales Market Share by Type (2025-2030)
Table 54. Global PEGylated Proteins Revenue (US$ Million) by Type (2019-2024)
Table 55. Global PEGylated Proteins Revenue (US$ Million) by Type (2025-2030)
Table 56. Global PEGylated Proteins Revenue Market Share by Type (2019-2024)
Table 57. Global PEGylated Proteins Revenue Market Share by Type (2025-2030)
Table 58. Global PEGylated Proteins Price (USD/MT) by Type (2019-2024)
Table 59. Global PEGylated Proteins Price (USD/MT) by Type (2025-2030)
Table 60. Global PEGylated Proteins Sales (K MT) by Application (2019-2024)
Table 61. Global PEGylated Proteins Sales (K MT) by Application (2025-2030)
Table 62. Global PEGylated Proteins Sales Market Share by Application (2019-2024)
Table 63. Global PEGylated Proteins Sales Market Share by Application (2025-2030)
Table 64. Global PEGylated Proteins Revenue (US$ Million) by Application (2019-2024)
Table 65. Global PEGylated Proteins Revenue (US$ Million) by Application (2025-2030)
Table 66. Global PEGylated Proteins Revenue Market Share by Application (2019-2024)
Table 67. Global PEGylated Proteins Revenue Market Share by Application (2025-2030)
Table 68. Global PEGylated Proteins Price (USD/MT) by Application (2019-2024)
Table 69. Global PEGylated Proteins Price (USD/MT) by Application (2025-2030)
Table 70. ENZON Pharmaceuticals Corporation Information
Table 71. ENZON Pharmaceuticals Description and Business Overview
Table 72. ENZON Pharmaceuticals PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. ENZON Pharmaceuticals PEGylated Proteins Product
Table 74. ENZON Pharmaceuticals Recent Developments/Updates
Table 75. Merck Sharp & Dohme Corporation Information
Table 76. Merck Sharp & Dohme Description and Business Overview
Table 77. Merck Sharp & Dohme PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Merck Sharp & Dohme PEGylated Proteins Product
Table 79. Merck Sharp & Dohme Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Roche PEGylated Proteins Product
Table 84. Roche Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Pfizer PEGylated Proteins Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Amgen PEGylated Proteins Product
Table 94. Amgen Recent Developments/Updates
Table 95. UCB Corporation Information
Table 96. UCB Description and Business Overview
Table 97. UCB PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. UCB PEGylated Proteins Product
Table 99. UCB Recent Developments/Updates
Table 100. Crealta (Savient) Corporation Information
Table 101. Crealta (Savient) Description and Business Overview
Table 102. Crealta (Savient) PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Crealta (Savient) PEGylated Proteins Product
Table 104. Crealta (Savient) Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. PEGylated Proteins Distributors List
Table 108. PEGylated Proteins Customers List
Table 109. PEGylated Proteins Market Trends
Table 110. PEGylated Proteins Market Drivers
Table 111. PEGylated Proteins Market Challenges
Table 112. PEGylated Proteins Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PEGylated Proteins
Figure 2. Global PEGylated Proteins Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global PEGylated Proteins Market Share by Type in 2023 & 2030
Figure 4. Colony Stimulating Factors Product Picture
Figure 5. Interferons Product Picture
Figure 6. Erythropoietin (EPO) Product Picture
Figure 7. Recombinant Factor VIII Product Picture
Figure 8. Monoclonal Antibodies Product Picture
Figure 9. Others Product Picture
Figure 10. Global PEGylated Proteins Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global PEGylated Proteins Market Share by Application in 2023 & 2030
Figure 12. Cancer Treatment
Figure 13. Hepatitis
Figure 14. Chronic Kidney Disease
Figure 15. Leukemia
Figure 16. SCID
Figure 17. Rheumatoid Arthritis & Crohn's Disease
Figure 18. Others
Figure 19. Global PEGylated Proteins Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global PEGylated Proteins Market Size (2019-2030) & (US$ Million)
Figure 21. Global PEGylated Proteins Sales (2019-2030) & (K MT)
Figure 22. Global PEGylated Proteins Average Price (USD/MT) & (2019-2030)
Figure 23. PEGylated Proteins Report Years Considered
Figure 24. PEGylated Proteins Sales Share by Manufacturers in 2023
Figure 25. Global PEGylated Proteins Revenue Share by Manufacturers in 2023
Figure 26. The Global 5 and 10 Largest PEGylated Proteins Players: Market Share by Revenue in 2023
Figure 27. PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 28. Global PEGylated Proteins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 29. North America PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 30. North America PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 31. U.S. PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Europe PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 34. Europe PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 35. Germany PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. France PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. U.K. PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Italy PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Russia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Asia Pacific PEGylated Proteins Sales Market Share by Region (2019-2030)
Figure 41. Asia Pacific PEGylated Proteins Revenue Market Share by Region (2019-2030)
Figure 42. China PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Japan PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. South Korea PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. India PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Australia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. China Taiwan PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Indonesia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Thailand PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Malaysia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Latin America PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 52. Latin America PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 53. Mexico PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Brazil PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Argentina PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 58. Turkey PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. UAE PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of PEGylated Proteins by Type (2019-2030)
Figure 62. Global Revenue Market Share of PEGylated Proteins by Type (2019-2030)
Figure 63. Global PEGylated Proteins Price (USD/MT) by Type (2019-2030)
Figure 64. Global Sales Market Share of PEGylated Proteins by Application (2019-2030)
Figure 65. Global Revenue Market Share of PEGylated Proteins by Application (2019-2030)
Figure 66. Global PEGylated Proteins Price (USD/MT) by Application (2019-2030)
Figure 67. PEGylated Proteins Value Chain
Figure 68. PEGylated Proteins Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global PEGylated Proteins Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global PEGylated Proteins Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global PEGylated Proteins Market Competitive Situation by Manufacturers in 2023
Table 4. Global PEGylated Proteins Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global PEGylated Proteins Sales Market Share by Manufacturers (2019-2024)
Table 6. Global PEGylated Proteins Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global PEGylated Proteins Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market PEGylated Proteins Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of PEGylated Proteins, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PEGylated Proteins, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PEGylated Proteins, Product Type & Application
Table 12. Global Key Manufacturers of PEGylated Proteins, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PEGylated Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEGylated Proteins as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PEGylated Proteins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global PEGylated Proteins Sales by Region (2019-2024) & (K MT)
Table 18. Global PEGylated Proteins Sales Market Share by Region (2019-2024)
Table 19. Global PEGylated Proteins Sales by Region (2025-2030) & (K MT)
Table 20. Global PEGylated Proteins Sales Market Share by Region (2025-2030)
Table 21. Global PEGylated Proteins Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global PEGylated Proteins Revenue Market Share by Region (2019-2024)
Table 23. Global PEGylated Proteins Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global PEGylated Proteins Revenue Market Share by Region (2025-2030)
Table 25. North America PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 27. North America PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 28. North America PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 32. Europe PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 33. Europe PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific PEGylated Proteins Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific PEGylated Proteins Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific PEGylated Proteins Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific PEGylated Proteins Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific PEGylated Proteins Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 42. Latin America PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 43. Latin America PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa PEGylated Proteins Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa PEGylated Proteins Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa PEGylated Proteins Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa PEGylated Proteins Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa PEGylated Proteins Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global PEGylated Proteins Sales (K MT) by Type (2019-2024)
Table 51. Global PEGylated Proteins Sales (K MT) by Type (2025-2030)
Table 52. Global PEGylated Proteins Sales Market Share by Type (2019-2024)
Table 53. Global PEGylated Proteins Sales Market Share by Type (2025-2030)
Table 54. Global PEGylated Proteins Revenue (US$ Million) by Type (2019-2024)
Table 55. Global PEGylated Proteins Revenue (US$ Million) by Type (2025-2030)
Table 56. Global PEGylated Proteins Revenue Market Share by Type (2019-2024)
Table 57. Global PEGylated Proteins Revenue Market Share by Type (2025-2030)
Table 58. Global PEGylated Proteins Price (USD/MT) by Type (2019-2024)
Table 59. Global PEGylated Proteins Price (USD/MT) by Type (2025-2030)
Table 60. Global PEGylated Proteins Sales (K MT) by Application (2019-2024)
Table 61. Global PEGylated Proteins Sales (K MT) by Application (2025-2030)
Table 62. Global PEGylated Proteins Sales Market Share by Application (2019-2024)
Table 63. Global PEGylated Proteins Sales Market Share by Application (2025-2030)
Table 64. Global PEGylated Proteins Revenue (US$ Million) by Application (2019-2024)
Table 65. Global PEGylated Proteins Revenue (US$ Million) by Application (2025-2030)
Table 66. Global PEGylated Proteins Revenue Market Share by Application (2019-2024)
Table 67. Global PEGylated Proteins Revenue Market Share by Application (2025-2030)
Table 68. Global PEGylated Proteins Price (USD/MT) by Application (2019-2024)
Table 69. Global PEGylated Proteins Price (USD/MT) by Application (2025-2030)
Table 70. ENZON Pharmaceuticals Corporation Information
Table 71. ENZON Pharmaceuticals Description and Business Overview
Table 72. ENZON Pharmaceuticals PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. ENZON Pharmaceuticals PEGylated Proteins Product
Table 74. ENZON Pharmaceuticals Recent Developments/Updates
Table 75. Merck Sharp & Dohme Corporation Information
Table 76. Merck Sharp & Dohme Description and Business Overview
Table 77. Merck Sharp & Dohme PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Merck Sharp & Dohme PEGylated Proteins Product
Table 79. Merck Sharp & Dohme Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Roche PEGylated Proteins Product
Table 84. Roche Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Pfizer PEGylated Proteins Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Amgen PEGylated Proteins Product
Table 94. Amgen Recent Developments/Updates
Table 95. UCB Corporation Information
Table 96. UCB Description and Business Overview
Table 97. UCB PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. UCB PEGylated Proteins Product
Table 99. UCB Recent Developments/Updates
Table 100. Crealta (Savient) Corporation Information
Table 101. Crealta (Savient) Description and Business Overview
Table 102. Crealta (Savient) PEGylated Proteins Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Crealta (Savient) PEGylated Proteins Product
Table 104. Crealta (Savient) Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. PEGylated Proteins Distributors List
Table 108. PEGylated Proteins Customers List
Table 109. PEGylated Proteins Market Trends
Table 110. PEGylated Proteins Market Drivers
Table 111. PEGylated Proteins Market Challenges
Table 112. PEGylated Proteins Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PEGylated Proteins
Figure 2. Global PEGylated Proteins Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global PEGylated Proteins Market Share by Type in 2023 & 2030
Figure 4. Colony Stimulating Factors Product Picture
Figure 5. Interferons Product Picture
Figure 6. Erythropoietin (EPO) Product Picture
Figure 7. Recombinant Factor VIII Product Picture
Figure 8. Monoclonal Antibodies Product Picture
Figure 9. Others Product Picture
Figure 10. Global PEGylated Proteins Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global PEGylated Proteins Market Share by Application in 2023 & 2030
Figure 12. Cancer Treatment
Figure 13. Hepatitis
Figure 14. Chronic Kidney Disease
Figure 15. Leukemia
Figure 16. SCID
Figure 17. Rheumatoid Arthritis & Crohn's Disease
Figure 18. Others
Figure 19. Global PEGylated Proteins Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global PEGylated Proteins Market Size (2019-2030) & (US$ Million)
Figure 21. Global PEGylated Proteins Sales (2019-2030) & (K MT)
Figure 22. Global PEGylated Proteins Average Price (USD/MT) & (2019-2030)
Figure 23. PEGylated Proteins Report Years Considered
Figure 24. PEGylated Proteins Sales Share by Manufacturers in 2023
Figure 25. Global PEGylated Proteins Revenue Share by Manufacturers in 2023
Figure 26. The Global 5 and 10 Largest PEGylated Proteins Players: Market Share by Revenue in 2023
Figure 27. PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 28. Global PEGylated Proteins Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 29. North America PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 30. North America PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 31. U.S. PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Canada PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Europe PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 34. Europe PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 35. Germany PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. France PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. U.K. PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Italy PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Russia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Asia Pacific PEGylated Proteins Sales Market Share by Region (2019-2030)
Figure 41. Asia Pacific PEGylated Proteins Revenue Market Share by Region (2019-2030)
Figure 42. China PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Japan PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. South Korea PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. India PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Australia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. China Taiwan PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Indonesia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Thailand PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Malaysia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Latin America PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 52. Latin America PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 53. Mexico PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Brazil PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Argentina PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa PEGylated Proteins Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa PEGylated Proteins Revenue Market Share by Country (2019-2030)
Figure 58. Turkey PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. UAE PEGylated Proteins Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of PEGylated Proteins by Type (2019-2030)
Figure 62. Global Revenue Market Share of PEGylated Proteins by Type (2019-2030)
Figure 63. Global PEGylated Proteins Price (USD/MT) by Type (2019-2030)
Figure 64. Global Sales Market Share of PEGylated Proteins by Application (2019-2030)
Figure 65. Global Revenue Market Share of PEGylated Proteins by Application (2019-2030)
Figure 66. Global PEGylated Proteins Price (USD/MT) by Application (2019-2030)
Figure 67. PEGylated Proteins Value Chain
Figure 68. PEGylated Proteins Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232